FDA’s Adequate & Well-Controlled Trials Checklist
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA reviewers did a point-by-point assessment of Sanofi’s CAMMS323 and CAMMS324 trials of Lemtrada per the criteria laid out in federal regulations.